nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—OPRM1—telencephalic ventricle—schizophrenia	0.227	0.419	CbGeAlD
Methadyl Acetate—OPRM1—forebrain—schizophrenia	0.0594	0.109	CbGeAlD
Methadyl Acetate—OPRM1—telencephalon—schizophrenia	0.0546	0.101	CbGeAlD
Methadyl Acetate—OPRM1—blood—schizophrenia	0.0397	0.0732	CbGeAlD
Methadyl Acetate—OPRM1—midbrain—schizophrenia	0.0392	0.0723	CbGeAlD
Methadyl Acetate—OPRM1—endocrine gland—schizophrenia	0.0345	0.0635	CbGeAlD
Methadyl Acetate—OPRM1—nervous system—schizophrenia	0.0322	0.0594	CbGeAlD
Methadyl Acetate—OPRM1—central nervous system—schizophrenia	0.031	0.0572	CbGeAlD
Methadyl Acetate—OPRM1—brain—schizophrenia	0.0246	0.0454	CbGeAlD
Methadyl Acetate—Orphenadrine—GRIN2D—schizophrenia	0.0148	0.0811	CrCbGaD
Methadyl Acetate—Clidinium—CHRM1—schizophrenia	0.0135	0.0742	CrCbGaD
Methadyl Acetate—Levomethadyl Acetate—CHRNA3—schizophrenia	0.0121	0.0661	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—FES—schizophrenia	0.0116	0.0423	CbGpPWpGaD
Methadyl Acetate—Isopropamide—CHRM1—schizophrenia	0.0115	0.0631	CrCbGaD
Methadyl Acetate—Doxylamine—CHRM1—schizophrenia	0.0115	0.0631	CrCbGaD
Methadyl Acetate—Mepenzolate—CHRM1—schizophrenia	0.0109	0.0596	CrCbGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PPP1R1B—schizophrenia	0.0107	0.0391	CbGpPWpGaD
Methadyl Acetate—Orphenadrine—GRIN1—schizophrenia	0.00999	0.0548	CrCbGaD
Methadyl Acetate—Diphenidol—CHRM1—schizophrenia	0.00953	0.0523	CrCbGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PPP3CC—schizophrenia	0.0094	0.0342	CbGpPWpGaD
Methadyl Acetate—Benzphetamine—SLC18A2—schizophrenia	0.00923	0.0506	CrCbGaD
Methadyl Acetate—Disopyramide—CHRM1—schizophrenia	0.00872	0.0478	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CCKAR—schizophrenia	0.00607	0.0221	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PDE4B—schizophrenia	0.00574	0.0209	CbGpPWpGaD
Methadyl Acetate—Methadone—HTR3A—schizophrenia	0.00559	0.0306	CrCbGaD
Methadyl Acetate—Propiomazine—CHRM1—schizophrenia	0.00502	0.0275	CrCbGaD
Methadyl Acetate—Propiomazine—DRD4—schizophrenia	0.00445	0.0244	CrCbGaD
Methadyl Acetate—Modafinil—SLC6A3—schizophrenia	0.00441	0.0242	CrCbGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—NTS—schizophrenia	0.0043	0.0156	CbGpPWpGaD
Methadyl Acetate—Promethazine—CHRM1—schizophrenia	0.00423	0.0232	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GRM2—schizophrenia	0.00401	0.0146	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IL10—schizophrenia	0.00394	0.0143	CbGpPWpGaD
Methadyl Acetate—Benzphetamine—SLC6A3—schizophrenia	0.00383	0.021	CrCbGaD
Methadyl Acetate—Propiomazine—DRD1—schizophrenia	0.00377	0.0207	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—RGS4—schizophrenia	0.00341	0.0124	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GRM3—schizophrenia	0.00341	0.0124	CbGpPWpGaD
Methadyl Acetate—Propiomazine—HTR2C—schizophrenia	0.00322	0.0177	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00319	0.0116	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PLA2G4A—schizophrenia	0.00318	0.0116	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.0031	0.0113	CbGpPWpGaD
Methadyl Acetate—Modafinil—CYP1A2—schizophrenia	0.00301	0.0165	CrCbGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCK—schizophrenia	0.00298	0.0108	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00288	0.0105	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCKAR—schizophrenia	0.00285	0.0104	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.00274	0.00997	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00266	0.00967	CbGpPWpGaD
Methadyl Acetate—Propiomazine—DRD2—schizophrenia	0.00266	0.0146	CrCbGaD
Methadyl Acetate—Tamoxifen—ESR1—schizophrenia	0.00264	0.0145	CrCbGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—NPY—schizophrenia	0.00259	0.00941	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—FZD3—schizophrenia	0.00258	0.00939	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—OXT—schizophrenia	0.0025	0.00908	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—TAAR6—schizophrenia	0.00243	0.00883	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GRM2—schizophrenia	0.00243	0.00883	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—NPS—schizophrenia	0.00237	0.00861	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00235	0.00855	CbGpPWpGaD
Methadyl Acetate—Dextropropoxyphene—CYP2D6—schizophrenia	0.00229	0.0126	CrCbGaD
Methadyl Acetate—Promethazine—DRD2—schizophrenia	0.00224	0.0123	CrCbGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00224	0.00813	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—NTS—schizophrenia	0.00219	0.00798	CbGpPWpGaD
Methadyl Acetate—Loperamide—CYP2D6—schizophrenia	0.00219	0.012	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—NPY—schizophrenia	0.00218	0.00794	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00217	0.00788	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—HTR1B—schizophrenia	0.00211	0.00766	CbGpPWpGaD
Methadyl Acetate—Diphenhydramine—CYP1A2—schizophrenia	0.00209	0.0115	CrCbGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—FOS—schizophrenia	0.00207	0.00753	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GRM3—schizophrenia	0.00206	0.00751	CbGpPWpGaD
Methadyl Acetate—Propiomazine—HTR2A—schizophrenia	0.00205	0.0113	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP1A2—schizophrenia	0.00203	0.0112	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—HTR1A—schizophrenia	0.00203	0.00737	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR6—schizophrenia	0.00203	0.00737	CbGpPWpGaD
Methadyl Acetate—Methadone—CYP1A2—schizophrenia	0.00202	0.0111	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.002	0.00727	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00195	0.00711	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00191	0.00697	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—DRD3—schizophrenia	0.0019	0.0069	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00188	0.00684	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00186	0.00676	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—DRD4—schizophrenia	0.00184	0.00669	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00182	0.00661	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00182	0.00661	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CHRM1—schizophrenia	0.00179	0.00651	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00176	0.0064	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CNR1—schizophrenia	0.00176	0.00639	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00173	0.00631	CbGpPWpGaD
Methadyl Acetate—Promethazine—HTR2A—schizophrenia	0.00173	0.00948	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DGKI—schizophrenia	0.00172	0.00624	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—DRD2—schizophrenia	0.00171	0.00624	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00171	0.00621	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00167	0.00609	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00167	0.00609	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GRM5—schizophrenia	0.00166	0.00605	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00163	0.00593	CbGpPWpGaD
Methadyl Acetate—Diphenhydramine—CYP2D6—schizophrenia	0.00161	0.00884	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00161	0.00586	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00159	0.00579	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00159	0.00579	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00159	0.00577	CbGpPWpGaD
Methadyl Acetate—Promethazine—CYP2D6—schizophrenia	0.00158	0.00867	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP2D6—schizophrenia	0.00157	0.00861	CrCbGaD
Methadyl Acetate—Loperamide—ABCB1—schizophrenia	0.00156	0.00856	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DGKI—schizophrenia	0.00156	0.00567	CbGpPWpGaD
Methadyl Acetate—Methadone—CYP2D6—schizophrenia	0.00156	0.00853	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00156	0.00566	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00156	0.00566	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—schizophrenia	0.00153	0.00558	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCK—schizophrenia	0.00152	0.00553	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00151	0.00548	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00146	0.00532	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCKAR—schizophrenia	0.00146	0.0053	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00142	0.00518	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADORA2A—schizophrenia	0.00141	0.00514	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.0014	0.00508	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM2—schizophrenia	0.00137	0.00499	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—TAAR6—schizophrenia	0.00137	0.00499	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00136	0.00496	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00136	0.00496	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—FZD3—schizophrenia	0.00132	0.00482	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—NPY—schizophrenia	0.00132	0.00481	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR1B—schizophrenia	0.00127	0.00464	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—OXT—schizophrenia	0.00127	0.00464	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NGEF—schizophrenia	0.00127	0.00462	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PPP3CC—schizophrenia	0.00125	0.00453	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM2—schizophrenia	0.00125	0.00453	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TAAR6—schizophrenia	0.00125	0.00453	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NTS—schizophrenia	0.00124	0.00451	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR1A—schizophrenia	0.00123	0.00446	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—NPS—schizophrenia	0.00121	0.0044	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR2C—schizophrenia	0.00118	0.00431	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD1—schizophrenia	0.00118	0.00431	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM3—schizophrenia	0.00117	0.00424	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RGS4—schizophrenia	0.00117	0.00424	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NGEF—schizophrenia	0.00115	0.00419	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD3—schizophrenia	0.00115	0.00417	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR6—schizophrenia	0.00114	0.00416	CbGpPWpGaD
Methadyl Acetate—Promethazine—ABCB1—schizophrenia	0.00113	0.00619	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NTS—schizophrenia	0.00113	0.0041	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCB1—schizophrenia	0.00112	0.00615	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—schizophrenia	0.00112	0.00406	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00111	0.00405	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD4—schizophrenia	0.00111	0.00405	CbGpPWpGaD
Methadyl Acetate—Methadone—ABCB1—schizophrenia	0.00111	0.00609	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CNR1—schizophrenia	0.00106	0.00387	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RGS4—schizophrenia	0.00106	0.00385	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM3—schizophrenia	0.00106	0.00385	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR6—schizophrenia	0.00104	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—DRD2—schizophrenia	0.00104	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR7—schizophrenia	0.00104	0.00378	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CHRM1—schizophrenia	0.00101	0.00368	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL3RA—schizophrenia	0.000985	0.00358	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000955	0.00347	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM5—schizophrenia	0.00094	0.00342	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DGKI—schizophrenia	0.00092	0.00335	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CHRM1—schizophrenia	0.000918	0.00334	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL3RA—schizophrenia	0.000895	0.00325	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCK—schizophrenia	0.00086	0.00313	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM5—schizophrenia	0.000853	0.0031	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PPP1R1B—schizophrenia	0.000842	0.00306	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE4B—schizophrenia	0.000838	0.00305	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—schizophrenia	0.000828	0.00301	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCKAR—schizophrenia	0.000824	0.003	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000799	0.00291	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FZD3—schizophrenia	0.000782	0.00285	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCK—schizophrenia	0.000781	0.00284	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE4B—schizophrenia	0.000761	0.00277	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCKAR—schizophrenia	0.000748	0.00272	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NPY—schizophrenia	0.000747	0.00272	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TAAR6—schizophrenia	0.000736	0.00268	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PPP3CC—schizophrenia	0.000736	0.00268	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM2—schizophrenia	0.000736	0.00268	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FES—schizophrenia	0.000736	0.00268	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—schizophrenia	0.000727	0.00264	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADORA2A—schizophrenia	0.000726	0.00264	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR1B—schizophrenia	0.00072	0.00262	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—OXT—schizophrenia	0.00072	0.00262	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR1A—schizophrenia	0.000693	0.00252	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NPS—schizophrenia	0.000683	0.00248	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NGEF—schizophrenia	0.000681	0.00248	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NPY—schizophrenia	0.000678	0.00247	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR2C—schizophrenia	0.00067	0.00244	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD1—schizophrenia	0.00067	0.00244	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NTS—schizophrenia	0.000665	0.00242	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR1B—schizophrenia	0.000654	0.00238	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—OXT—schizophrenia	0.000654	0.00238	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD3—schizophrenia	0.000649	0.00236	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR1A—schizophrenia	0.00063	0.00229	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD4—schizophrenia	0.00063	0.00229	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RGS4—schizophrenia	0.000625	0.00228	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM3—schizophrenia	0.000625	0.00228	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RTN4—schizophrenia	0.000625	0.00228	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NPS—schizophrenia	0.00062	0.00226	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR6—schizophrenia	0.000614	0.00223	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR2C—schizophrenia	0.000608	0.00221	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD1—schizophrenia	0.000608	0.00221	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CNR1—schizophrenia	0.000601	0.00219	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAG—schizophrenia	0.000593	0.00216	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD3—schizophrenia	0.000589	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—DRD2—schizophrenia	0.000587	0.00213	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR7—schizophrenia	0.000587	0.00213	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD4—schizophrenia	0.000572	0.00208	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CNR1—schizophrenia	0.000546	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CHRM1—schizophrenia	0.000542	0.00197	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—DRD2—schizophrenia	0.000533	0.00194	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR7—schizophrenia	0.000533	0.00194	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL3RA—schizophrenia	0.000528	0.00192	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TLE1—schizophrenia	0.000516	0.00188	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NRG3—schizophrenia	0.000516	0.00188	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GFAP—schizophrenia	0.00051	0.00185	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM5—schizophrenia	0.000504	0.00183	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TLE3—schizophrenia	0.000488	0.00178	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCK—schizophrenia	0.000461	0.00168	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE4B—schizophrenia	0.000449	0.00163	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCKAR—schizophrenia	0.000442	0.00161	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADORA2A—schizophrenia	0.000429	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000421	0.00153	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGA—schizophrenia	0.000411	0.0015	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—schizophrenia	0.000411	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NPY—schizophrenia	0.0004	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ATP2A2—schizophrenia	0.0004	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH4—schizophrenia	0.0004	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR1B—schizophrenia	0.000386	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—OXT—schizophrenia	0.000386	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—schizophrenia	0.000373	0.00136	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR1A—schizophrenia	0.000372	0.00135	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NPS—schizophrenia	0.000366	0.00133	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR2C—schizophrenia	0.000359	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD1—schizophrenia	0.000359	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NTRK2—schizophrenia	0.000349	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD3—schizophrenia	0.000348	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD4—schizophrenia	0.000338	0.00123	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CNR1—schizophrenia	0.000322	0.00117	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DRD2—schizophrenia	0.000315	0.00114	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR7—schizophrenia	0.000315	0.00114	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRL—schizophrenia	0.000297	0.00108	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—S100B—schizophrenia	0.000277	0.00101	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ERBB4—schizophrenia	0.000265	0.000963	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLA2G4A—schizophrenia	0.000249	0.000906	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NRG1—schizophrenia	0.000244	0.000889	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MEF2C—schizophrenia	0.000242	0.000881	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—YWHAZ—schizophrenia	0.000234	0.000852	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ERBB3—schizophrenia	0.000229	0.000833	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR2A—schizophrenia	0.00022	0.000802	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOE—schizophrenia	0.000205	0.000745	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOA1—schizophrenia	0.000203	0.000737	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ESR1—schizophrenia	0.000196	0.000712	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GSK3B—schizophrenia	0.000177	0.000645	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—schizophrenia	0.000132	0.000478	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT1—schizophrenia	0.000119	0.000434	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EP300—schizophrenia	0.000117	0.000425	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TP53—schizophrenia	8.35e-05	0.000304	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT1—schizophrenia	7.05e-05	0.000257	CbGpPWpGaD
